These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38763480)

  • 1. Design, synthesis and molecular docking study of novel triazole-quinazolinone hybrids as antimalarial and antitubercular agents.
    Mhetre UV; Haval NB; Bondle GM; Rathod SS; Choudhari PB; Kumari J; Sriram D; Haval KP
    Bioorg Med Chem Lett; 2024 Aug; 108():129800. PubMed ID: 38763480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
    Phatak PS; Bakale RD; Kulkarni RS; Dhumal ST; Dixit PP; Krishna VS; Sriram D; Khedkar VM; Haval KP
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127579. PubMed ID: 32987135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
    Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
    Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
    Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4169-73. PubMed ID: 26298500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
    Patil PS; Kasare SL; Haval NB; Khedkar VM; Dixit PP; Rekha EM; Sriram D; Haval KP
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127434. PubMed ID: 32717369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
    Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D
    Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Click chemistry based regioselective one-pot synthesis of coumarin-3-yl-methyl-1,2,3-triazolyl-1,2,4-triazol-3(4H)-ones as newer potent antitubercular agents.
    Somagond SM; Kamble RR; Bayannavar PK; Shaikh SKJ; Joshi SD; Kumbar VM; Nesaragi AR; Kariduraganavar MY
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900013. PubMed ID: 31397503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3-Triazoles: A Computational Docking Techniques.
    Sadineni K; Reddy Basireddy S; Rao Allaka T; Yatam S; Bhoomandla S; Muvvala V; Babu Haridasyam S
    Chem Biodivers; 2024 May; 21(5):e202400389. PubMed ID: 38457745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Antiplasmodial Evaluation of Sulfoximine-triazole Hybrids as Potential Antimalarial Prototypes.
    Mabasa TF; Awe B; Laming D; Kinfe HH
    Med Chem; 2019; 15(6):685-692. PubMed ID: 30727905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and bio-evaluation of alkylaminoaryl phenyl cyclopropyl methanones as antitubercular and antimalarial agents.
    Ajay A; Singh V; Singh S; Pandey S; Gunjan S; Dubey D; Sinha SK; Singh BN; Chaturvedi V; Tripathi R; Ramchandran R; Tripathi RP
    Bioorg Med Chem; 2010 Dec; 18(23):8289-301. PubMed ID: 21041091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
    Suresh A; Srinivasarao S; Agnieszka N; Ewa AK; Alvala M; Lherbet C; Chandra Sekhar KVG
    Chem Biol Drug Des; 2018 Jun; 91(6):1078-1086. PubMed ID: 29063733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
    Xu Z; Zhang S; Song X; Qiang M; Lv Z
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Hemoglobin Degrading Protease Falcipain-2 as a Mechanism for Anti-Malarial Activity of Triazole-Amino Acid Hybrids.
    Singh V; Hada RS; Uddin A; Aneja B; Abid M; Pandey KC; Singh S
    Curr Top Med Chem; 2020; 20(5):377-389. PubMed ID: 32000644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Click synthesis of 1,2,3-triazole based imidazoles: Antitubercular evaluation, molecular docking and HSA binding studies.
    Pradeep Kumar CB; Prathibha BS; Prasad KNN; Raghu MS; Prashanth MK; Jayanna BK; Alharthi FA; Chandrasekhar S; Revanasiddappa HD; Yogesh Kumar K
    Bioorg Med Chem Lett; 2021 Mar; 36():127810. PubMed ID: 33482292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.
    Agarwal A; Srivastava K; Puri SK; Sinha S; Chauhan PM
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5218-21. PubMed ID: 16171994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
    Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
    Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and antitubercular assessment of 1, 2, 3-triazole incorporated thiazolylcarboxylate derivatives.
    Bakale RD; Sulakhe SM; Kasare SL; Sathe BP; Rathod SS; Choudhari PB; Madhu Rekha E; Sriram D; Haval KP
    Bioorg Med Chem Lett; 2024 Jan; 97():129551. PubMed ID: 37979730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.